Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.123.001789Source: DataRank Database

Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.56)OA: bronzeTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Donna A. Nguyen,Marcio de Araujo Furtado,Jérôme Niquet ORCID,Emily Linz,Caroline R. Schultz ORCID

Live enrichment

PubMed:37977809 PMC:PMC10801783 OpenAlex:https://openalex.org/W4388775868

NINDS NIH HHS

Grant: U01 NS074926

NIH HHS

Grant: AOD21005001

National Institutes of Health

Grant: 3U01NS074926-01S1

Rational polytherapy in the treatment of cholinergic seizures

FWCI

1.56

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttps://jpet.aspetjournals.org/content/jpet/early/2023/11/17/jpet.123.001789.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/early/2023/11/17/jpet.123.001789.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524171698?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524171698?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/jpet.123.001789

Fields of Study

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatmentMemory and Neural Mechanisms03 medical and health sciences0302 clinical medicineRatsMaleAnimalsMidazolamLacosamideKetamineSomanAnticonvulsantsStatus EpilepticusSeizuresBenzodiazepinesCholinergic Agentsgamma-Aminobutyric AcidTriazoles

MeSH Terms

LacosamideAnimalsAnticonvulsantsBenzodiazepinesgamma-Aminobutyric AcidKetamineMaleMidazolamSeizuresSomanStatus EpilepticusTriazolesCholinergic AgentsRats

Keywords

LacosamideStatus epilepticusPharmacologyMidazolamMedicineAnesthesiaBenzodiazepineKetamineSomanFlumazenilNeuroscienceEpilepsyChemistryPsychologyInternal medicineSedationAcetylcholinesteraseReceptorMaleCholinergic AgentsTriazolesRatsBenzodiazepinesSeizuresAnimalsAnticonvulsantsgamma-Aminobutyric Acid

Sustainable Development Goals

SDG 0: Good health and well-being